How do glucocorticoids compare to oligo decoys as inhibitors of collagen synthesis and potential toxicity of these therapeutics?
- 24 March 2004
- journal article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 92 (1), 6-15
- https://doi.org/10.1002/jcb.20030
Abstract
This article demonstrates how glucocorticoids decrease collagen synthesis. The parameters used to assess procollagen synthesis in our laboratory will be compared to those used by others. This article will note all the pertinent literature on the molecular mechanisms of this down regulation of procollagen synthesis. For example, what are the effects of glucocorticoids at the levels of transcription and translation of collagen mRNAs? Finally, we will define a molecular mechanism to inhibit Type I collagen synthesis by decreasing the binding of the TGF‐β activator protein complex to the TGF‐β element in the distal promoter of the proα1 Type I collagen gene, preventing the 2:1 ratio of α1 to α2 chains in the processed Type I collagen molecule. We will next ask “How do sense oligo decoys decrease Type I collagen synthesis at the in vivo and at the cell levels?” In primary fibrotic cell culture, the double‐stranded phosphorothioate oligodeoxynucleotide decoys were more effective than their sense single‐stranded counterparts. The molecular mechanism for the decrease in Type I collagen synthesis is the same as glucocorticoids, that is by decreasing the binding of the TGF‐β activator protein complex to the TGF‐β element in the distal promoter of the proα1 Type I collagen gene for the transcription of the proα1 mRNAs. The reason for using sense oligo decoys as anti‐fibrotic agents as compared to the anti‐fibrotic glucocorticoids, is that presently marketed and FDA approved glucocorticoids have many untoward side effects which the sense oligo decoys do not have.Keywords
This publication has 48 references indexed in Scilit:
- Transforming growth factor‐β: crossroad of glucocorticoid and bleomycin regulation of collagen synthesis in lung fibroblastsWound Repair and Regeneration, 1999
- Major suppression of pro-α1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonideJournal of the American Academy of Dermatology, 1997
- Abrogation of the fibrotic effect of transforming growth factor‐β in dermal wound healingWound Repair and Regeneration, 1997
- Recovery of human skin collagen synthesis after short-term topical corticosteroid treatment and comparison between young and old subjectsBritish Journal of Dermatology, 1996
- Tumour necrosis factor a, interferon γ and dexamethasone regulate IGF-I-maintained collagen production in cultured human fibroblastsJournal of Endocrinology, 1995
- Topical mometasone furoate and betamethasone-17-valerate decrease collagen synthesis to a similar extent in human skin in vivoBritish Journal of Dermatology, 1995
- Systemic glucocorticoids decrease the synthesis of type I and type III collagen in human skin in vivo, whereas isotretinoin treatment has little effectBritish Journal of Dermatology, 1994
- Anti-inflammatory prednisolone derivatives inhibit collagen synthesis and pro-alpha1 (I) collagen promoter activity in rat skin fibroblastsWound Repair and Regeneration, 1994
- Variation of corticosteroid-induced inhibition of collagen synthesis at equivalent anti-inflammatory dosesJournal of the American Academy of Dermatology, 1990
- Bleomycin selectively elevates mRNA levels for procollagen and fibronectin following acute lung injuryBiochemical and Biophysical Research Communications, 1985